-
Study aim
-
Effect of Spirulina as a nutritional supplement and drug in Covid-19 patients
-
Design
-
clinical trial with control group , with parallel groups , double-blind , randomized , phase 2on 100 patients.Random Allocation software was used for randomization.
-
Settings and conduct
-
In this study,100 patients with positive covid-19 PCR referred to Imam Reza hospital in Tabriz was randomly admitted to one of the two groups which studied (two groups of drug and placebo). 50 patients entered the intervention group and 50 patients entered the placebo group. Patients information including age , gender , vital signs upon arrival, extent of pulmonary involvement were recorded by CT scan, underlying disease and medication used.patients in the intervention group received 1g of Spirulina capsule 4 time daily,the control group received starch-containing capsules as a placebo. then the patients were followed by telephone for 14 days. Participants and researchers compared the type of blinded capsule and the capsule information in a sealed envelope until the end of study. The effectiveness of the capsule in reducing clinical symptoms such as cough, fatigue and other symptoms, and the paraclinical findings as well as the possible side effects of the drug were measured.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Conformation of covid19 by PCR; consent to participate in the study
Exclusion criteria: underlying disease , pregnancy , discontinuation of the drug
-
Intervention groups
-
50patients received Spirulina capsule 4 time daily as an intervention group and 50 patients received a starch-containing capsule as a control group
-
Main outcome variables
-
Clinical symptoms(cough, fever, etc) ,paraclinical variables (wbc,IL-6, TNF) of the group receiving Spirulina and placebo in patient with COVID19 before and after the intervention